Bioverativ to Report Fourth Quarter and Year-End 2017 Financial Results on February 13, 2018
January 16 2018 - 4:15PM
Business Wire
Bioverativ Inc. (NASDAQ: BIVV) today announced it will report
fourth quarter and year-end 2017 financial results on Tuesday,
February 13, 2018, after the market closes. The press release will
be available in the “Investor Relations” section of the company’s
website at investors.bioverativ.com.
On Wednesday, February 14, 2018, at 8:00 a.m. EST, the company
will host a live webcast with Bioverativ management. To access the
live webcast, please visit Bioverativ’s Investors page at
investors.bioverativ.com. An archived version of the webcast will
be available following the presentation.
About Bioverativ
Bioverativ (NASDAQ: BIVV) is a global biopharmaceutical company
dedicated to transforming the lives of people with hemophilia and
other rare blood disorders through world-class research,
development and commercialization of innovative therapies. Launched
in 2017 following separation from Biogen Inc., Bioverativ builds
upon a strong heritage of scientific innovation and is committed to
actively working with the blood disorders community. The company’s
mission is to create progress for patients where they need it most
and its hemophilia therapies when launched represented the first
major advancements in hemophilia treatment in more than two
decades. For more information, visit www.bioverativ.com or follow
@bioverativ on Twitter.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20180116006152/en/
INVESTOR CONTACT:Bioverativ Inc.Sam Chase, +1
781-663-9277IR@bioverativ.com
Bioverativ Inc. (NASDAQ:BIVV)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bioverativ Inc. (NASDAQ:BIVV)
Historical Stock Chart
From Jul 2023 to Jul 2024